Stevanato Group S.p.A. (STVN)
NYSE: STVNHealth CareMedical/Dental InstrumentsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
STVN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.31B
- P/E (TTM)
- 34.71
- Forward P/E
- 23.10
- EPS (TTM)
- $0.56
- Dividend yield
- 0.31% ($0.00)
- Ex-dividend date
- Jun 11, 2026
- 52-week range
- 12.89 – 27.99
- Day range
- 19.18 – 19.67
- Volume / Avg
- 285.69K / 370.47K
- Beta
- —
- Shares outstanding
- 49.83M
- Next earnings
- Nov 5, 2026
52-week range
STVN stock today
Stevanato Group S.p.A. (STVN) closed at $19.44 on Oct 7, down 2.11% (-$0.42), versus the S&P 500's 0.22% decline. Shares are 30.5% below their 52-week high of $27.99, set on Oct 24, 2025 and 50.8% above the 52-week low of $12.89, in the middle of the past year's range. STVN is down 3.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 19.2%.
At 34.7x trailing earnings, Stevanato Group S.p.A. trades below the peer-group median of 44.4x. Its forward P/E of 23.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Stevanato Group S.p.A.'s next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Stevanato Group S.p.A.
Company profileStevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Franco Stevanato
- Headquarters
- Piombino Dese, PD
- Employees
- 6,010
- IPO year
- 2021
- Website
- stevanatogroup.com
Analyst forecast
ForecastConsensus (13 analysts)
buy
Avg. price target
$24.68+26.95%
- Strong buy 2
- Buy 7
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.18
Dividends
Dividend history- Annual dividend
- $0.00
- Dividend yield
- 0.31%
- Last payment
- $0.062
- Ex-dividend date
- Jun 11, 2026
Stevanato Group S.p.A. peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TFXTeleflex Incorporated | 124.48 | -0.21% | $5.27B | vs STVN |
| MMEDMiniMed Group Inc. | 19.11 | -2.70% | $5.38B | vs STVN |
| MMSIMerit Medical Systems Inc. | 85.09 | +0.15% | $5.08B | vs STVN |
| HAEHaemonetics Corporation | 101.71 | -1.75% | $4.63B | vs STVN |
| HTFLHeartflow Inc. | 49.36 | -2.62% | $4.29B | vs STVN |
| ICUIICU Medical Inc. | 156.03 | -2.32% | $3.90B | vs STVN |
| NVSTEnvista Holdings Corporation | 23.04 | -0.99% | $3.70B | vs STVN |
| PLSEPulse Biosciences Inc | 49.09 | -1.33% | $3.50B | vs STVN |
Indexes, lists and sector
Appears in lists
Stevanato Group S.p.A. stock FAQ
What is Stevanato Group S.p.A.'s stock price today?
STVN last traded at $19.44 as of Oct 7, 4:00 PM EDT, down 2.11% on the day. Prices are delayed at least 15 minutes.
Does Stevanato Group S.p.A. pay a dividend?
Yes. Stevanato Group S.p.A. pays $0.00 per share annually, a 0.31% yield. The most recent dividend of $0.062 had an ex-dividend date of Jun 11, 2026.
When is Stevanato Group S.p.A.'s next earnings date?
Stevanato Group S.p.A. is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.18.
What is STVN's P/E ratio?
STVN trades at a trailing P/E ratio of 34.71 and a forward P/E of 23.10, compared with a median of 44.4 for its closest peers.
Who is Stevanato Group S.p.A.'s CEO?
Mr. Franco Stevanato is the chief executive officer of Stevanato Group S.p.A., which has about 6,010 employees.
What is the STVN 52-week high?
The 52-week high for STVN is $27.99 and the 52-week low is $12.89. The stock is currently 30.5% below its high.